Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thorstensson

Showing results (281-290 of 342) with videos related to

Pageof 35
Sort By:
Transactions of the Royal Society of Tropical Medicine and Hygiene|January 1, 1995
Visceral leishmaniasis in Somalia: prevalence of leishmanin-positive and seropositive inhabitants in an endemic areaS A Shiddo, H O Akuffo, A A Mohamed, et al.
Bioorganic & Medicinal Chemistry|November 17, 2006
Synthesis of novel potent hepatitis C virus NS3 protease inhibitors: discovery of 4-hydroxy-cyclopent-2-ene-1,2-dicarboxylic acid as a N-acyl-L-hydroxyproline bioisostereFredrik Thorstensson, Fredrik Wångsell, Ingemar Kvarnström, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1989
Experimental infection of cynomolgus monkeys (Macaca fascicularis) with simian immunodeficiency virus (SIVsm)P Putkonen, K Warstedt, R Thorstensson, et al.
AIDS Research and Human Retroviruses|March 1, 1991
Vaccine protection against HIV-2 infection in cynomolgus monkeysP Putkonen, R Thorstensson, L Walther, et al.
The Journal of Infectious Diseases|November 1, 1996
Immunogenicity and protective efficacy of a human immunodeficiency virus type 2 recombinant canarypox (ALVAC) vaccine candidate in cynomolgus monkeysS Andersson, B Mäkitalo, R Thorstensson, et al.
Virology|October 30, 1998
Immune responses but no protection against SHIV by gene-gun delivery of HIV-1 DNA followed by recombinant subunit protein boostsP Putkonen, M Quesada-Rolander, A C Leandersson, et al.
AIDS Research and Human Retroviruses|March 31, 1998
Differences in reverse transcriptase activity versus p24 antigen detection in cell culture, when comparing a homogeneous group of HIV type 1 subtype B viruses with a heterogeneous group of divergent strainsG E Corrigan, L Al-Khalili, A Malmsten, et al.
AIDS (London, England)|December 24, 1998
Live attenuated simian immunodeficiency virus (SIV)mac in macaques can induce protection against mucosal infection with SIVsmC Nilsson, B Mäkitalo, R Thorstensson, et al.
Clinical and Experimental Immunology|February 26, 2005
Human immunodeficiency virus (HIV)-2-specific T lymphocyte proliferative responses in HIV-2-infected and in HIV-2-exposed but uninfected individuals in Guinea-BissauS Andersson, O Larsen, Z Da Silva, et al.
Acta Orthopaedica|May 3, 2014
Dissatisfied patients after total knee arthroplasty: a registry study involving 114 patients with 8-13 years of followupAbdulemir Ali, Martin Sundberg, Otto Robertsson, et al.
Pageof 35

Showing results (281-290 of 342) with videos related to

Sort By:
Pageof 35
Transactions of the Royal Society of Tropical Medicine and Hygiene|January 1, 1995
Visceral leishmaniasis in Somalia: prevalence of leishmanin-positive and seropositive inhabitants in an endemic areaS A Shiddo, H O Akuffo, A A Mohamed, et al.
Bioorganic & Medicinal Chemistry|November 17, 2006
Synthesis of novel potent hepatitis C virus NS3 protease inhibitors: discovery of 4-hydroxy-cyclopent-2-ene-1,2-dicarboxylic acid as a N-acyl-L-hydroxyproline bioisostereFredrik Thorstensson, Fredrik Wångsell, Ingemar Kvarnström, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1989
Experimental infection of cynomolgus monkeys (Macaca fascicularis) with simian immunodeficiency virus (SIVsm)P Putkonen, K Warstedt, R Thorstensson, et al.
AIDS Research and Human Retroviruses|March 1, 1991
Vaccine protection against HIV-2 infection in cynomolgus monkeysP Putkonen, R Thorstensson, L Walther, et al.
The Journal of Infectious Diseases|November 1, 1996
Immunogenicity and protective efficacy of a human immunodeficiency virus type 2 recombinant canarypox (ALVAC) vaccine candidate in cynomolgus monkeysS Andersson, B Mäkitalo, R Thorstensson, et al.
Virology|October 30, 1998
Immune responses but no protection against SHIV by gene-gun delivery of HIV-1 DNA followed by recombinant subunit protein boostsP Putkonen, M Quesada-Rolander, A C Leandersson, et al.
AIDS Research and Human Retroviruses|March 31, 1998
Differences in reverse transcriptase activity versus p24 antigen detection in cell culture, when comparing a homogeneous group of HIV type 1 subtype B viruses with a heterogeneous group of divergent strainsG E Corrigan, L Al-Khalili, A Malmsten, et al.
AIDS (London, England)|December 24, 1998
Live attenuated simian immunodeficiency virus (SIV)mac in macaques can induce protection against mucosal infection with SIVsmC Nilsson, B Mäkitalo, R Thorstensson, et al.
Clinical and Experimental Immunology|February 26, 2005
Human immunodeficiency virus (HIV)-2-specific T lymphocyte proliferative responses in HIV-2-infected and in HIV-2-exposed but uninfected individuals in Guinea-BissauS Andersson, O Larsen, Z Da Silva, et al.
Acta Orthopaedica|May 3, 2014
Dissatisfied patients after total knee arthroplasty: a registry study involving 114 patients with 8-13 years of followupAbdulemir Ali, Martin Sundberg, Otto Robertsson, et al.
Pageof 35